Sephience Powder
Product Images NDC 52856-201

Product Visual Gallery

This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Sephience (NDC 52856-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ptc Therapeutics Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Sephience 01)

Chemical structure diagram depicting the molecular structure of sepiapterin, the active ingredient in Sephience. The diagram shows atoms and bonds arranged to illustrate the compound's chemical composition.*

FDA Label Image

Figure 1 (Sephience 02)

A line graph comparing mean blood phenylalanine (Phe) levels in µmol/L over time between placebo and Sephience (sepiapterin) treatment groups. The timeline includes Open-label Sephience, Washout, and Double-Blind Placebo-Controlled phases, with mean Phe values and error bars shown at each measurement point.*

FDA Label Image

250mg Dose Packet (Sephience 03)

Sephience (sepiapterin) Oral Powder 250 mg per packet packaging label showing a box containing 30 unit-dose packets and a single packet label. The box and packet include usage and dosing directions and are labeled by PTC Therapeutics Inc.*

FDA Label Image

1000mg Dose Packet (Sephience 04)

Sephience (sepiapterin) Oral Powder 1,000 mg per packet packaging. The image shows a white outer box labeled with the brand name Sephience, the generic name sepiapterin, and strength 1,000 mg per packet. The box contains 30 unit-dose packets. Also visible is a single unit-dose packet with similar branding and dosage information. The labeler is PTC Therapeutics Inc.*

FDA Label Image

Figure A (Sephience 05)

An instructional diagram labeled Figure A showing items included and not included with Sephience oral powder packets. Included is the Sephience oral powder packets package. Not included are illustrations of an oral dosing syringe, scissors, a container for mixing, a water or apple juice cup, and a small spoon.*

FDA Label Image

Figure B (Sephience 06)

An instructional illustration showing a hand pouring Sephience (sepiapterin) powder from a 250 mg sachet into a small container labeled for mixing, demonstrating proper preparation for oral administration.*

FDA Label Image

Figure C (Sephience 07)

Illustration labeled 'Figure C' showing an oral dosing syringe with labeled parts (tip, barrel, plunger), a container holding powder for mixing, and a cup containing water or apple juice, used for preparing and administering Sephience oral powder.*

FDA Label Image

Figure D (Sephience 08)

Illustration showing a hand stirring a powder mixture in a small container labeled as "container for mixing," likely depicting preparation instructions for Sephience (sepiapterin) oral powder.*

FDA Label Image

Figure E (Sephience 09)

An instructional illustration showing a hand using a syringe to withdraw liquid from a small container labeled "container for mixing." This image demonstrates a step in the preparation or mixing process for an oral powder medication.*

FDA Label Image

Figure F (Sephience 10)

An instructional diagram labeled Figure F illustrating a hand holding a device with a marked tip and measurement markings, accompanied by an eye symbol indicating to observe the tip.*

FDA Label Image

Figure G (Sephience 11)

An instructional illustration labeled Figure G showing a person administering oral medication using a syringe. The syringe is positioned at the person's open mouth, indicating the proper technique for oral dosing.*

FDA Label Image

Figure A1 (Sephience 12)

Instructional illustration showing included and not included items with Sephience oral powder packets. Included is a packet of Sephience powder. Not included are a tablespoon, scissors, a container for mixing, cups of water or apple juice, a cup of applesauce or strawberry jam, and a cup of water or apple juice for rinsing.*

FDA Label Image

250mg Foil (Sephience 13)

Sephience (sepiapterin) oral powder, 1,000 mg per packet. Label includes directions to see enclosed instructions for use or administration and to take with food. The package contains a single unit-dose packet. Manufactured by PTC Therapeutics Inc.*

FDA Label Image

1000mg Foil (Sephience 14)

Sephience (sepiapterin) oral powder, 250 mg per packet, in a unit-dose packet. The label includes directions to use with food and to see enclosed instructions. The product is labeled by PTC Therapeutics Inc. and shows NDC 52856-201-01.*

FDA Label Image

Figure B1 (Sephience 15)

An illustration showing a hand pouring Sephience (sepiapterin) powder from a sachet labeled 1000 mg for oral use into a measuring container labeled 'container for mixing.' The image demonstrates how to empty the powder for mixing before administration.*

FDA Label Image

Figure C1 (Sephience 16)

An instructional illustration showing a tablespoon, a container for mixing powder, a cup labeled for applesauce or strawberry jam, and another cup labeled for water or apple juice. The image visually indicates options for mixing oral powder with these liquids or foods.*

FDA Label Image

Figure D1 (Sephience 17)

An instructional diagram showing a hand stirring a spoon inside a container labeled 'container for mixing.' This likely represents the process of mixing the Sephience (sepiapterin) oral powder before administration.*

FDA Label Image

Ndc: 52856-201-03 (250mg Carton Label)

Label for Sephience 250 mg oral powder packets. The label displays the proprietary name Sephience with the generic name sepiapterin, highlighting 250 mg per packet strength. It is an oral powder formulation, available in 30 unit-dose packets. The label includes storage instructions and notes PTC Therapeutics Inc. as the manufacturer. A barcode and NDC 52856-201-03 are also visible.*

FDA Label Image

Ndc: 52856-201-01 (250mg Sachet Label)

Sephience 250 mg oral powder front and back unit-dose packet labels. The front label states the proprietary name Sephience with the generic name sepiapterin and strength of 250 mg per packet. Instructions note to see enclosed directions for use and to take with food. The back label shows the manufacturer PTC Therapeutics, Inc., a barcode, and spaces for lot and expiration information.*

FDA Label Image

Ndc: 52856-201-01 (250mg Sachet Foil)

Packaging label for Sephience (sepiapterin) oral powder, 250 mg per packet, presented as individual unit-dose packets. The label includes directions to see enclosed instructions for administration and to take with food. Manufactured for PTC Therapeutics Inc., with a barcode and lot and expiration date fields included.*

FDA Label Image

Ndc: 52856-301-03 (1000mg Carton Label)

The image shows the unfolded carton packaging for Sephience (sepiapterin) Oral Powder, 1,000 mg per packet, a human prescription drug by PTC Therapeutics Inc. The carton indicates it contains 30 unit-dose packets and advises storage between 20°C to 25°C with some permitted variation. Usage directions note to see enclosed instructions and to take with food. The packaging includes the NDC 52856-301-03 and the PTC Therapeutics logo.*

FDA Label Image

Ndc: 52856-301-01 (1000mg Sachet Label)

Sephience 1000 mg oral powder packet label showing front and back views. The front label indicates Sephience (sepiapterin) oral powder with 1000 mg per packet in a single unit-dose packet, including a direction note to see enclosed instructions and to take with food. The back label states it is manufactured for PTC Therapeutics Inc., featuring the company logo, barcode, and spaces for lot and expiration information.*

FDA Label Image

Ndc: 52856-301-01 (1000mg Sachet Foil)

Label for Sephience (sepiapterin) Oral Powder, 1,000 mg per packet, presented as a unit-dose powder packet. The label includes the proprietary name, generic name, strength, and usage direction to take with food. It is manufactured for PTC Therapeutics Inc., with visible barcodes and placeholders for lot and expiration dates.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.